Healthcare

SB 2388 would allow human-use ivermectin (a medication approved by the FDA for parasitic infections) to be sold without a prescription in North Dakota. This change would directly affect pharmacies, consumers seeking the medication, and healthcare providers by removing the current requirement for a doctor's prescription. The bill proposes creating a new law in North Dakota's code that explicitly permits over-the-counter sales of ivermectin for human use. It does not address medical use, safety, or other forms of ivermectin, focusing solely on changing pharmacy access rules.

SB 2108 aimed to establish North Dakota as a member of a multi-state compact for physician assistant (PA) licensure. If passed, it would have allowed North Dakota-licensed PAs to practice in other participating states without obtaining separate licenses, directly benefiting PAs seeking to work across state lines and patients in those states. The bill would have created a new chapter (43-17.5) in North Dakota law to implement this compact agreement. However, the bill failed to pass on January 15, 2025, with 0 votes in favor and 47 against.